HK1214622A1 - 含用於純化芳基硫酸酯酶 的方法 - Google Patents
含用於純化芳基硫酸酯酶 的方法Info
- Publication number
- HK1214622A1 HK1214622A1 HK16102496.7A HK16102496A HK1214622A1 HK 1214622 A1 HK1214622 A1 HK 1214622A1 HK 16102496 A HK16102496 A HK 16102496A HK 1214622 A1 HK1214622 A1 HK 1214622A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- rylsulfatase
- purification
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/12—Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/06—Sulfuric ester hydrolases (3.1.6)
- C12Y301/06001—Arylsulfatase (3.1.6.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/06—Sulfuric ester hydrolases (3.1.6)
- C12Y301/06008—Cerebroside-sulfatase (3.1.6.8)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361750693P | 2013-01-09 | 2013-01-09 | |
PCT/US2014/010856 WO2014110246A1 (en) | 2013-01-09 | 2014-01-09 | Methods for purification of arylsulfatase a |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1214622A1 true HK1214622A1 (zh) | 2016-07-29 |
Family
ID=50002885
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16102496.7A HK1214622A1 (zh) | 2013-01-09 | 2016-03-04 | 含用於純化芳基硫酸酯酶 的方法 |
HK16104341.0A HK1216429A1 (zh) | 2013-01-09 | 2016-04-15 | 用於純化芳基硫酸酯酶 的方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16104341.0A HK1216429A1 (zh) | 2013-01-09 | 2016-04-15 | 用於純化芳基硫酸酯酶 的方法 |
Country Status (12)
Country | Link |
---|---|
US (2) | US11407984B2 (pt) |
EP (1) | EP2943568B1 (pt) |
JP (5) | JP6427502B2 (pt) |
CN (2) | CN112126634A (pt) |
AU (3) | AU2014205441B2 (pt) |
BR (1) | BR112015015948B1 (pt) |
CA (1) | CA2896979C (pt) |
EA (1) | EA030551B1 (pt) |
ES (1) | ES2768261T3 (pt) |
HK (2) | HK1214622A1 (pt) |
MX (2) | MX2015008875A (pt) |
WO (1) | WO2014110246A1 (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013009686A2 (en) * | 2011-07-08 | 2013-01-17 | Shire Human Genetic Therapies, Inc. | Methods for purification of arylsulfatase a |
EP2943568B1 (en) | 2013-01-09 | 2019-11-20 | Shire Human Genetic Therapies, Inc. | Methods for purification of arylsulfatase a |
JP6783767B2 (ja) * | 2014-12-22 | 2020-11-11 | アレクシオン ファーマシューティカルズ インコーポレイテッドAlexion Pharmaceuticals, Inc. | 組換えタンパク質を精製する方法 |
TW201718623A (zh) * | 2015-08-20 | 2017-06-01 | 建南德克公司 | FkpA之純化及其用於製備重組多肽之用途 |
CN109069592B (zh) * | 2016-03-16 | 2023-03-07 | 菲尼克斯组织修复公司 | 纯化胶原7的方法 |
JP6957738B2 (ja) * | 2017-08-31 | 2021-11-02 | グリーン・クロス・コーポレイションGreen Cross Corp. | スルファターゼタンパク質を精製する方法 |
BR112020012637A2 (pt) * | 2017-12-19 | 2020-12-01 | Shire Human Genetic Therapies, Inc | arilsulfatase a purificada e composições da mesma |
SG11202006506TA (en) * | 2018-02-02 | 2020-08-28 | Enzyvant Therapeutics Gmbh | Methods for treating farber disease |
US20210163531A1 (en) * | 2018-04-12 | 2021-06-03 | Amgen Inc. | Methods for making stable protein compositions |
CN112082832B (zh) * | 2019-06-12 | 2022-03-29 | 华南理工大学 | 一种保存城市污水中硫酸酯结合体和葡萄糖苷醛酸结合体的方法 |
CN110632052A (zh) * | 2019-10-25 | 2019-12-31 | 山西师范大学 | 土壤芳基硫酸酯酶活性的荧光光谱检测法 |
CN112759643B (zh) * | 2021-03-17 | 2023-05-30 | 华兰生物工程股份有限公司 | 一种血清白蛋白的脱脂方法 |
CN116693659A (zh) * | 2023-07-11 | 2023-09-05 | 浙江大学 | 一种分离重组人血白蛋白的两步混合模式层析方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4314997A (en) | 1980-10-06 | 1982-02-09 | Edward Shanbrom | Purification of plasma protein products |
US4315919A (en) | 1980-10-06 | 1982-02-16 | Edward Shanbrom | Depyrogenation process |
US4764369A (en) | 1983-07-14 | 1988-08-16 | New York Blood Center Inc. | Undenatured virus-free biologically active protein derivatives |
CA2041280A1 (en) * | 1990-05-10 | 1991-11-11 | Yosuke Sawada | Arylsulfatase |
NO960163D0 (no) | 1996-01-15 | 1996-01-15 | Thomas Berg | Mutasjonsdeteksjon av bovin |
CA2319096C (en) | 1998-01-27 | 2007-07-03 | Hemebiotech A/S | Method for treating acute intermittent porphyria (aip) and other porphyric diseases |
DK2270044T3 (en) | 1998-06-09 | 2015-01-26 | Csl Behring Ag | Liquid immunoglobulin G (IgG) product |
PT1084147E (pt) | 1998-06-09 | 2005-01-31 | Statens Seruminstitut | Processo para producao de imunoglobulinas para administracao intravenosa e outros produtos de imunoglobulina |
AUPQ026799A0 (en) | 1999-05-10 | 1999-06-03 | Csl Limited | Method of increasing protein stability by removing immunoglobulin aggregates |
EP1202744B1 (en) | 1999-07-27 | 2006-01-04 | Zymenex A/S | PRODUCTION OF rhPBGD |
US6812339B1 (en) | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
WO2002040686A2 (en) | 2000-11-15 | 2002-05-23 | Genzyme Corporation | Expression system for recombinant proteins |
AU2002317701A1 (en) | 2001-06-07 | 2002-12-16 | Hemebiotech A/S | Production of recombinant human lysosomal alpha-mannosidase |
WO2002098455A2 (en) * | 2001-06-07 | 2002-12-12 | Hemebiotech A/S | Production of recombinant human arylsulfatase a |
EP1402014A1 (en) | 2001-06-29 | 2004-03-31 | Hemebiotech A/S | A process for purification of recombinant porphobilinogen deaminase |
US7232670B2 (en) | 2001-09-28 | 2007-06-19 | St. Jude Children's Research Hospital | Targeting proteins to cells expressing mannose receptors via expression in insect cells |
JP2006506317A (ja) | 2002-01-11 | 2006-02-23 | バイオマリン ファーマシューティカル インコーポレイテッド | 治療用リソソーム酵素の送達のための酵素送達系としてのp97の使用 |
AU2003212912A1 (en) | 2002-02-04 | 2003-09-02 | Millipore Corporation | Process for removing protein aggregates and virus from a protein solution |
NZ589037A (en) | 2004-01-30 | 2011-10-28 | Shire Pharmaceuticals Ireland Ltd | Production and purification of recombinant arylsulfatase A |
DK1740204T3 (en) | 2004-04-01 | 2018-05-22 | Chiesi Farm Spa | MEDICAL USE OF ALFA MANNOSIDASE |
US20060051347A1 (en) | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
CA2644642C (en) | 2006-04-04 | 2016-01-26 | Zymenex A/S | A process for concentration of a polypeptide |
CN105646643A (zh) * | 2008-10-29 | 2016-06-08 | 阿布林克斯公司 | 单域抗原结合性分子的纯化方法 |
US8945895B2 (en) * | 2009-07-31 | 2015-02-03 | Baxter International Inc. | Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof |
RU2671503C2 (ru) | 2010-06-25 | 2018-11-01 | Шир Хьюман Дженетик Терапис, Инк. | Способы и композиции для доставки в цнс арилсульфатазы а |
KR102211960B1 (ko) | 2010-06-25 | 2021-02-05 | 샤이어 휴먼 지네틱 테라피즈 인크. | 치료제들의 cns 전달 |
GB201012603D0 (en) * | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Protein purification |
EP2943568B1 (en) | 2013-01-09 | 2019-11-20 | Shire Human Genetic Therapies, Inc. | Methods for purification of arylsulfatase a |
-
2014
- 2014-01-09 EP EP14701454.2A patent/EP2943568B1/en active Active
- 2014-01-09 BR BR112015015948-6A patent/BR112015015948B1/pt active IP Right Grant
- 2014-01-09 CA CA2896979A patent/CA2896979C/en active Active
- 2014-01-09 AU AU2014205441A patent/AU2014205441B2/en active Active
- 2014-01-09 ES ES14701454T patent/ES2768261T3/es active Active
- 2014-01-09 CN CN202011058581.6A patent/CN112126634A/zh active Pending
- 2014-01-09 US US14/759,645 patent/US11407984B2/en active Active
- 2014-01-09 EA EA201590826A patent/EA030551B1/ru not_active IP Right Cessation
- 2014-01-09 WO PCT/US2014/010856 patent/WO2014110246A1/en active Application Filing
- 2014-01-09 JP JP2015551870A patent/JP6427502B2/ja active Active
- 2014-01-09 MX MX2015008875A patent/MX2015008875A/es active IP Right Grant
- 2014-01-09 CN CN201480003307.5A patent/CN104903442A/zh active Pending
-
2015
- 2015-07-08 MX MX2020003798A patent/MX2020003798A/es unknown
-
2016
- 2016-03-04 HK HK16102496.7A patent/HK1214622A1/zh unknown
- 2016-04-15 HK HK16104341.0A patent/HK1216429A1/zh unknown
-
2018
- 2018-06-28 JP JP2018122837A patent/JP2018171067A/ja not_active Withdrawn
-
2019
- 2019-09-25 JP JP2019174155A patent/JP2020015750A/ja not_active Withdrawn
-
2020
- 2020-02-14 AU AU2020201079A patent/AU2020201079B2/en active Active
-
2021
- 2021-11-10 JP JP2021183082A patent/JP7407161B2/ja active Active
-
2022
- 2022-07-01 US US17/810,396 patent/US11884945B2/en active Active
- 2022-08-25 AU AU2022221475A patent/AU2022221475A1/en active Pending
-
2023
- 2023-10-04 JP JP2023173170A patent/JP2024001160A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EA201590826A1 (ru) | 2015-11-30 |
HK1216429A1 (zh) | 2016-11-11 |
AU2020201079A1 (en) | 2020-03-05 |
BR112015015948A2 (pt) | 2017-08-15 |
US11884945B2 (en) | 2024-01-30 |
AU2014205441B2 (en) | 2019-12-12 |
MX2015008875A (es) | 2015-10-22 |
BR112015015948B1 (pt) | 2022-05-17 |
MX2020003798A (es) | 2020-08-03 |
WO2014110246A1 (en) | 2014-07-17 |
AU2022221475A1 (en) | 2022-09-22 |
CA2896979A1 (en) | 2014-07-17 |
CN104903442A (zh) | 2015-09-09 |
JP2018171067A (ja) | 2018-11-08 |
CA2896979C (en) | 2023-05-02 |
CN112126634A (zh) | 2020-12-25 |
JP2016504040A (ja) | 2016-02-12 |
US20150353904A1 (en) | 2015-12-10 |
EP2943568B1 (en) | 2019-11-20 |
AU2020201079B2 (en) | 2022-05-26 |
JP2020015750A (ja) | 2020-01-30 |
JP2022023225A (ja) | 2022-02-07 |
JP6427502B2 (ja) | 2018-11-21 |
AU2014205441A1 (en) | 2015-06-25 |
US20230235303A1 (en) | 2023-07-27 |
EA030551B1 (ru) | 2018-08-31 |
US11407984B2 (en) | 2022-08-09 |
ES2768261T3 (es) | 2020-06-22 |
JP2024001160A (ja) | 2024-01-09 |
EP2943568A1 (en) | 2015-11-18 |
JP7407161B2 (ja) | 2023-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190197T1 (hr) | Postupci pročišćavanja rna | |
IL240215A0 (en) | Methods for the purification of messenger RNA | |
PL2803401T3 (pl) | Oczyszczanie powietrza | |
HK1216429A1 (zh) | 用於純化芳基硫酸酯酶 的方法 | |
GB201401248D0 (en) | Method of manufacture | |
SG11201603028SA (en) | Purification of proteins | |
SG11201505198WA (en) | Protein purification methods | |
HK1218014A1 (zh) | 用以間接判定參考間距的方法 | |
IL268868B (en) | A new method for protein purification | |
PL2985275T3 (pl) | Sposób oczyszczania kwasu beta-hydroksy-beta-metylomasłowego | |
HK1222339A1 (zh) | 金屬-β-內酰胺酶的抑制劑 | |
IL240763B (en) | The halopyrazoles as thrombin inhibitors | |
EP2948557A4 (en) | PURIFICATION OF CADAVERINE | |
ZA201603797B (en) | Novel purification processes | |
GB201305231D0 (en) | Method of Manufacture | |
IL243937A0 (en) | A process for the purification of diaminophenothiazinium compounds | |
GB201305514D0 (en) | Method of water purification | |
HK1216419A1 (zh) | 合成方法 | |
PL3063156T3 (pl) | Sposób oczyszczania lecytyny | |
GB201314581D0 (en) | Purification | |
SG10201701021XA (en) | Method of synthesis | |
GB201311291D0 (en) | Method of manufacture | |
GB201301262D0 (en) | Method of manufacture | |
TWM475821U (en) | Structure of mosquito-catch | |
TWM475524U (en) | Structure of rivet-pulling |